AU3697899A - Diagnostic agent for mr diagnosis - Google Patents

Diagnostic agent for mr diagnosis

Info

Publication number: AU3697899A
Authority: AU; Australia
Prior art keywords: diagnosis; diagnostic agent; diagnostic; agent
Prior art date: 1998-05-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Pharma AG

Original Assignee

Institut fuer Diagnostikforschung GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-05Priority claimed from DE1998120847external-prioritypatent/DE19820847A1/en

1999-03-01Application filed by Institut fuer Diagnostikforschung GmbHfiledCriticalInstitut fuer Diagnostikforschung GmbH

1999-11-23Publication of AU3697899ApublicationCriticalpatent/AU3697899A/en

StatusAbandonedlegal-statusCriticalCurrent

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1887—Agglomerates, clusters, i.e. more than one (super)(para)magnetic microparticle or nanoparticle are aggregated or entrapped in the same maxtrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1866—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle the nanoparticle having a (super)(para)magnetic core coated or functionalised with a peptide, e.g. protein, polyamino acid

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Nanotechnology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Radiology & Medical Imaging (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AU36978/99A1998-05-051999-03-01Diagnostic agent for mr diagnosisAbandonedAU3697899A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE1998120847DE19820847A1 (en)	1998-05-05	1998-05-05	Diagnostic agents for magnetic resonance imaging
DE19820847		1998-05-05
US8593898P	1998-05-20	1998-05-20
US60085938		1998-05-20
PCT/DE1999/000588WO1999056786A1 (en)	1998-05-05	1999-03-01	Diagnostic agent for mr diagnosis

Publications (1)

Publication Number	Publication Date
AU3697899Atrue AU3697899A (en)	1999-11-23

Family

ID=26046087

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU36978/99AAbandonedAU3697899A (en)	1998-05-05	1999-03-01	Diagnostic agent for mr diagnosis

Country Status (2)

Country	Link
AU (1)	AU3697899A (en)
WO (1)	WO1999056786A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7115417B1 (en)	1998-05-01	2006-10-03	Chancellor Michael B	Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof
US6866842B1 (en)	1998-05-01	2005-03-15	University Of Pittsburgh	Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
CA2406393C (en)	2000-04-14	2012-10-02	University Of Pittsburgh	Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
MY136493A (en)*	2000-09-28	2008-10-31	Uni Charm Corp	Absorbent article and barrier agent for absorbent article
CA2438904C (en)	2001-02-23	2012-09-04	The University Of Pittsburgh	Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
US9617516B2 (en)	2003-04-25	2017-04-11	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Muscle-derived cells (MDCs) for promoting and enhancing nerve repair and regeneration
ES2678416T3 (en)	2007-01-11	2018-08-10	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Muscle-derived cells for the treatment of urinary tract pathologies and methods of manufacturing and using them
WO2009027937A2 (en)*	2007-08-31	2009-03-05	Koninklijke Philips Electronics N. V.	Clustered magnetic particles as tracers for magnetic particle imaging
CA2734858C (en)	2008-08-18	2019-01-15	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH04323560A (en)*	1991-04-22	1992-11-12	Nippon Telegr & Teleph Corp <Ntt>	Magnetic particle labelling material for use in laser magnetic immunity measurement and adjusting method for subject

1999
- 1999-03-01AUAU36978/99Apatent/AU3697899A/ennot_activeAbandoned
- 1999-03-01WOPCT/DE1999/000588patent/WO1999056786A1/enactiveSearch and Examination

Also Published As

Publication number	Publication date
WO1999056786A1 (en)	1999-11-11

Publication	Publication Date	Title
AU2276495A (en)	1995-11-10	Contrast agents for diagnostic imaging
AU3891499A (en)	1999-11-29	Diagnostic tests for alzheimer's disease
AU1818695A (en)	1995-09-18	Gas-containing microcapsules useful as contrast agents for diagnostic imaging
AU5864296A (en)	1996-12-11	Diagnostic imaging x-ray contrast agents
HUP0101245A3 (en)	2003-10-28	Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
AU1239300A (en)	2000-06-13	Diagnostic medical ultrasound method and system for contrast agent imaging
GB2340648B (en)	2002-09-25	Tyre diagnostic system
AU5567299A (en)	2000-04-26	Hand held ultrasonic diagnostic instrument
AU2032400A (en)	2000-06-19	Monitor for interventional procedures
AUPQ886100A0 (en)	2000-08-10	Diagnostic test
AU4562693A (en)	1994-01-31	Contrast agents for mr diagnosis
AU2765799A (en)	1999-11-23	Gantry for medical imaging system
AU2068299A (en)	1999-08-02	Ultrasound contrast imaging
AU5981599A (en)	2000-04-10	Mri contrast agent
AU3697899A (en)	1999-11-23	Diagnostic agent for mr diagnosis
AU3436295A (en)	1996-05-02	Diagnostic imaging agent
AU4202997A (en)	1998-02-25	Diagnostic imaging contrast agent with improved in-serum-relaxivity
GB9800534D0 (en)	1998-03-11	Diagnostic system
AU6105199A (en)	2000-04-17	Diagnostic method
AU2002212960A1 (en)	2002-04-29	Diagnostic system for monitoring physiological conditions
AU2823795A (en)	1996-01-19	2,4,6-triiodo-5-substituted-amino-isophthalate esters useful as x-ray contrast agents for medical diagnostic imaging
GB2364577B (en)	2003-11-26	Diagnostic system
AU1163101A (en)	2001-05-30	Diagnostic methods
AU4115997A (en)	1998-02-25	Diagnostic imaging contrast agent with improved in-serum-relaxivity
AU6509698A (en)	1998-10-22	Methods for clinical diagnosis

Legal Events

Date	Code	Title	Description
2001-01-25	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

Movatterモバイル変換

AU3697899A - Diagnostic agent for mr diagnosis - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (5)

Publications (1)

Family

ID=26046087

Family Applications (1)

Country Status (2)

Families Citing this family (9)

Family Cites Families (1)

Also Published As

Similar Documents

Legal Events